Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.

Abstract

GUIDELINE QUESTION: What is the role of strontium-89 in effective palliative care of patients with stage D endocrine-refractory prostate cancer and multiple sites of painful bone metastases? OBJECTIVE: To make recommendations about the routine use of 89Sr in this clinical setting.

Authors

Brundage MD; Crook JM; Lukka H

Journal

Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC, Vol. 2, No. 2, pp. 79–87

Publication Date

April 1998

ISSN

1206-548X

Associated Experts

Himu Lukka

Professor, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 4203 Health Services and Systems 42 Health Sciences 3202 Clinical Sciences 3211 Oncology and Carcinogenesis

Medical Subject Headings (MeSH)

Bone Marrow Bone Neoplasms Humans Male Palliative Care Prostatic Neoplasms Randomized Controlled Trials as Topic Strontium Radioisotopes